Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
Collegium Pharmaceutical (Nasdaq: COLL) has announced its participation in the 24th Annual Needham Healthcare Conference, which will be held virtually from April 7-10, 2025. The company's management will engage in a fireside chat scheduled for Tuesday, April 8, 2025, at 9:30 a.m. ET.
The fireside discussion will be accessible through a live webcast on the Investors section of Collegium's website. Interested parties can view the presentation at https://ir.collegiumpharma.com, and a replay will remain available on the company's website for 90 days following the event.
Collegium Pharmaceutical (Nasdaq: COLL) ha annunciato la sua partecipazione alla 24ª Conferenza Annuale di Needham sulla Salute, che si terrà virtualmente dal 7 al 10 aprile 2025. La direzione dell'azienda parteciperà a una chiacchierata informale programmata per martedì 8 aprile 2025, alle 9:30 a.m. ET.
La discussione informale sarà accessibile tramite una diretta streaming nella sezione Investitori del sito web di Collegium. Le parti interessate possono visualizzare la presentazione su https://ir.collegiumpharma.com, e una registrazione sarà disponibile sul sito dell'azienda per 90 giorni dopo l'evento.
Collegium Pharmaceutical (Nasdaq: COLL) ha anunciado su participación en la 24ª Conferencia Anual de Salud de Needham, que se llevará a cabo de forma virtual del 7 al 10 de abril de 2025. La dirección de la empresa participará en una charla informal programada para martes, 8 de abril de 2025, a las 9:30 a.m. ET.
La discusión informal será accesible a través de una transmisión en vivo en la sección de Inversores del sitio web de Collegium. Las partes interesadas pueden ver la presentación en https://ir.collegiumpharma.com, y una repetición estará disponible en el sitio de la empresa durante 90 días después del evento.
Collegium Pharmaceutical (Nasdaq: COLL)는 제24회 니드햄 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2025년 4월 7일부터 10일까지 가상으로 진행됩니다. 회사 경영진은 2025년 4월 8일 화요일 오전 9시 30분 ET에 예정된 대화에 참여할 예정입니다.
대화는 Collegium 웹사이트의 투자자 섹션을 통해 실시간 웹캐스트로 접근할 수 있습니다. 관심 있는 분들은 https://ir.collegiumpharma.com에서 발표를 시청할 수 있으며, 이벤트 후 90일 동안 회사 웹사이트에서 재생이 가능합니다.
Collegium Pharmaceutical (Nasdaq: COLL) a annoncé sa participation à la 24e Conférence Annuelle de Needham sur la Santé, qui se tiendra virtuellement du 7 au 10 avril 2025. La direction de l'entreprise participera à une discussion informelle prévue pour mardi 8 avril 2025, à 9h30 ET.
La discussion sera accessible via un webinaire en direct dans la section Investisseurs du site web de Collegium. Les parties intéressées peuvent visionner la présentation à l'adresse https://ir.collegiumpharma.com, et un enregistrement sera disponible sur le site de l'entreprise pendant 90 jours après l'événement.
Collegium Pharmaceutical (Nasdaq: COLL) hat seine Teilnahme an der 24. jährlichen Needham Healthcare-Konferenz bekannt gegeben, die vom 7. bis 10. April 2025 virtuell stattfindet. Das Management des Unternehmens wird an einem informellen Gespräch teilnehmen, das für Dienstag, den 8. April 2025, um 9:30 Uhr ET geplant ist.
Die Diskussion wird über einen Live-Stream im Investorenbereich der Collegium-Website zugänglich sein. Interessierte können die Präsentation unter https://ir.collegiumpharma.com ansehen, und eine Wiederholung wird 90 Tage lang nach der Veranstaltung auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
STOUGHTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that management will participate in a fireside chat at the 24th Annual Needham Healthcare Conference being held virtually from April 7-10, 2025.
Details of the event are as follows:
Fireside Chat Date and Time: Tuesday, April 8, 2025, at 9:30 a.m. ET
The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Collegium Pharmaceutical, Inc.
Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and recently acquired Jornay PM®, a treatment for ADHD, establishing a presence in neuropsychiatry. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contacts:
Ian Karp
Head of Investor Relations
ir@collegiumpharma.com
Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com
Media Contact:
Cheryl Wheeler
Head of Corporate Communications
communications@collegiumpharma.com
FAQ
When is Collegium Pharmaceutical (COLL) presenting at the Needham Healthcare Conference 2025?
How can investors watch Collegium's (COLL) Needham Conference presentation?
How long will Collegium's (COLL) Needham Conference presentation be available for replay?
What type of presentation will Collegium (COLL) give at the 2025 Needham Healthcare Conference?
